RecruitingNCT06915584

Drug Management in Heart Failure


Sponsor

IRCCS San Raffaele Roma

Enrollment

450 participants

Start Date

Nov 30, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Aim of the proposal is to create an interactive AI-based multicentre prospective database to provide information on how to improve the QoC for pts with HF.This will provide detailed information on pts characteristics,treatment practices, adherence to prescribed guideline-based optimal drug therapy,and outcomes.The database stems from a registry started two years ago,conceived to provide a contemporary snapshot on the adherence to the latest European GGLL for the therapeutic management of pts with HF.The database will be integrated with a specifically designed algorithm that provides an accurate feedback on whether patients are properly treated according to the ESC most recent recommendations.The expected outcomes are:-define non-adherence level to GGLL-based recommendations for treatment of HF;-provide information on initiation, adherence and persistence over time of the recommended treatment;-reduce medical inertia;produce practical implications to reduce morbidity and mortality


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Both gender
  • Age \>18 years
  • Signed informed consent for the study
  • Known diagnosis of heart failure \> 6 months
  • Recent or ongoing hospitalization for heart failure exacerbation

Exclusion Criteria4

  • Conditions that, in the investigator's judgment, may interfere with the study or contraindicate participation for safety reasons
  • Concurrent diagnosis of neoplasia
  • Advanced COPD (FEV1 \<50%)
  • Advanced valvular heart disease (severe mitral-aortic stenosis-insufficiency requiring cardiac surgery)

Locations(1)

IRCCs San Raffaele

Rome, RM, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06915584


Related Trials